FDA Expands Use of Breast Cancer Drug Kisqali

Monthly News Roundup - October 2024

drugs.com - 31/Oct 00:10

FDA Approves AbbVie’s Vyalev to Treat Advanced Parkinson Disease In October, the US Food and Drug Administration (FDA) approved Vyalev...

Shorla Oncology Announces U.S. FDA Expanded Approval of Jylamvo (methotrexate), an Oncology and Autoimmune Drug for Pediatric Indications

drugs.com - 29/Oct 10:10

CAMBRIDGE, Mass.--(BUSINESS WIRE) October 29, 2024 --Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company,...

AIA Philippines expands Hope for the Breast program – free breast cancer screenings in Metro Manila

philstar.com - 30/Oct 02:16

With over 27,000 women in the Philippines diagnosed with breast cancer in 2021 alone, the need for early detection and treatment has never been more...

Key findings could boost Dimerix’s rare kidney disease drug trial

stockhead.com.au - 28/Oct 19:35

Medical collab PARASOL has broadened potential surrogate endpoints for FDA approval of treatments for a rare kidney disease treatment, potentially ...

FDA Approves Orlynvah (sulopenem etzadroxil and probenecid) for the Treatment of Uncomplicated Urinary Tract Infections

drugs.com - 25/Oct 21:10

DUBLIN and CHICAGO, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), today announced that the U.S. Food and Drug...

FDA Approves Emrosi (minocycline hydrochloride) for the Treatment of Rosacea

drugs.com - 04/Nov 00:11

SCOTTSDALE, Ariz., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage...

Gene signature shows promise to improve survival for breast cancer patients

oncologynews.com.au - 06/Nov 16:17

Using a gene signature technique to tailor chemotherapy for patients with early triple-negative breast cancer shows promise as a way to improve...

Novartis Scemblix Granted FDA Accelerated Approval in Newly Diagnosed CML

drugs.com - 29/Oct 10:10

East Hanover, October 29, 2024 – Novartis announced today that Scemblix (asciminib) was granted accelerated approval by the US Food and Drug...

Ionis Announces FDA Acceptance of New Drug Application for Donidalorsen for Prophylactic Treatment of HAE

drugs.com - 04/Nov 23:11

CARLSBAD, Calif., Nov. 4, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration...

Pakistan Association of the Deaf hosts Breast Cancer Awareness Session for Deaf Women at The Hive

biztoday.news - 26/Oct 15:10

News Desk KARACHI: The Pakistan Association of the Deaf (PAD) successfully hosted a Breast Cancer Awareness Session for Deaf Women on Saturday, 26...

Rubriques :